Skip to content

Search for:

Storm Riders Network

Into This World We're Thrown

Facebook
Instagram
Twitter
LinkedIn

MENUMENU

ABOUT
- Mission
- My Story
SCIENCE & RESEARCH
RESOURCES
- Organizations
- News & Publications

Category: Mutations

A phase I study of alpelisib + trastuzumab + LJM716 for PIK3CA-mutated HER2+ metastatic breast cancer

PARP inhibitors improve survival in metastatic breast cancer

Posts navigation

Latest News

Researchers engineer cells to destroy malignant tumor cells but leave the rest alone
June 28, 2021
Bone-protective effects of everolimus for premenopausal HR+/HER2-neg metastatic breast cancer
June 15, 2021
ASCO 2021: IMpassion130 analysis identifies tumor immune phenotypes and molecular subtypes most likely to respond to atezolizumab
June 15, 2021
ASCO 2021: Addition of palbociclib to fulvestrant attains overall survival benefit in advanced breast cancer with update of PALOMA-3
June 15, 2021

Stay Connected

Subscribe to this blog and receive notifications of new posts.

Email Address

Upcoming Events

Apr 14

April 14 - April 19

AACR 2023 Annual Meeting

May 6

May 6 - May 8

NBCC’s 2023 Advocacy Leadership Summit

Loading Comments...

Write a Comment...

Email

Name

Website